SELVAS Healthcare, Inc. (KOSDAQ:208370)
South Korea · Delayed Price · Currency is KRW 2,595.00
+145.00 (5.92%)
At close: Jul 27, 2026
SELVAS Healthcare Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 68,923 | 149,419 | 104,285 | 175,241 | 45,264 | 64,973 | |
Market Cap Growth | -37.67% | 43.28% | -40.49% | 287.15% | -30.33% | 19.76% |
Enterprise Value | 31,457 | 129,955 | 83,142 | 154,677 | 46,475 | 68,550 |
Last Close Price | 2680.00 | 5810.00 | 4055.00 | 6830.00 | 2021.01 | 2900.97 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.15 | 38.42 | 33.09 | 33.90 | 16.09 | 26.29 |
Forward PE | - | 20.30 | 20.30 | 20.30 | 20.30 | 20.30 |
PS Ratio | 2.28 | 4.85 | 3.29 | 5.88 | 1.64 | 2.23 |
PB Ratio | 0.82 | 2.10 | 1.64 | 2.92 | 1.34 | 2.32 |
P/TBV Ratio | 0.85 | 2.19 | 1.71 | 3.06 | 1.47 | 2.62 |
P/FCF Ratio | 64.72 | - | 27.56 | 56.31 | - | 25.41 |
P/OCF Ratio | 31.23 | 490.29 | 23.18 | 50.48 | 890.94 | 22.19 |
PEG Ratio | - | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.04 | 4.22 | 2.62 | 5.19 | 1.68 | 2.36 |
EV/EBITDA Ratio | 30.07 | 168.16 | 19.23 | 35.48 | 12.96 | 13.72 |
EV/EBIT Ratio | 264.52 | - | 25.39 | 46.18 | 18.69 | 20.07 |
EV/FCF Ratio | 29.54 | - | 21.98 | 49.70 | - | 26.81 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.05 | 0.05 | 0.23 | 0.60 |
Debt / EBITDA Ratio | 1.31 | 2.23 | 0.69 | 0.74 | 2.18 | 3.35 |
Debt / FCF Ratio | 1.34 | - | 0.79 | 1.04 | - | 6.55 |
Net Debt / Equity Ratio | -0.44 | -0.35 | -0.36 | -0.35 | 0.02 | 0.07 |
Net Debt / EBITDA Ratio | -34.52 | -31.90 | -5.34 | -4.83 | 0.22 | 0.38 |
Net Debt / FCF Ratio | -35.18 | 44.66 | -6.10 | -6.76 | -2.56 | 0.74 |
Asset Turnover | 0.37 | 0.41 | 0.46 | 0.53 | 0.58 | 0.62 |
Inventory Turnover | 1.83 | 2.02 | 1.73 | 1.50 | 1.94 | 3.13 |
Quick Ratio | 9.31 | 7.00 | 6.40 | 4.80 | 1.23 | 1.08 |
Current Ratio | 11.96 | 9.15 | 8.08 | 6.64 | 2.44 | 1.54 |
Return on Equity (ROE) | 22.80% | 5.76% | 5.09% | 11.02% | 9.10% | 9.34% |
Return on Assets (ROA) | 0.12% | -0.14% | 2.99% | 3.71% | 3.27% | 4.54% |
Return on Invested Capital (ROIC) | 0.32% | -0.30% | 7.85% | 9.10% | 7.61% | 11.51% |
Return on Capital Employed (ROCE) | 0.20% | -0.20% | 5.10% | 5.50% | 6.70% | 10.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 24.55% | 2.60% | 3.02% | 2.95% | 6.21% | 3.80% |
FCF Yield | 1.55% | -0.37% | 3.63% | 1.78% | -0.67% | 3.94% |
Buyback Yield / Dilution | -2.81% | 0.12% | -6.86% | -2.31% | -9.11% | -0.02% |